Stop TB Partnership


3 May 2017 - Tashkent, Uzbekistan - Recognizing the importance of media engagement in combating the socially significant disease tuberculosis (TB), the United States Agency for International Development (USAID) today honored Iqboldjon Abdujabborov with a special recognition award at the prestigious international competition for the XII National Journalism Prize "Oltin Qalam" (The Gold Pencil). The award, recognizing the best media coverage of TB, was presented on May 3, 2017 - World Press Freedom Day - at an awards ceremony at Turkiston Palace in Tashkent. This is the second consecutive year USAID has presented this award.

In the past year, Iqboljon Abdujabborov from Ferghana published 15 articles on TB in Fargona Shifokori and on the (TB is Curable) website, which he recently launched as the only Uzbek-language platform in this creative format providing critical information about TB to the public throughout Uzbekistan.

Since 2005, the Creative Union of Uzbekistan’s Journalists and the In-Service Training Center of Uzbekistan’s Journalists have been holding the Oltin Qalam, the preeminent national journalism competition, to recognize outstanding achievements in international and national journalism and to foster public recognition of the important role journalists play in educating audiences and offering a critical and responsible view of public life. The Oltin Qalam special recognition awards are traditionally supported by national and international organizations accredited in Uzbekistan, including the UN, UNESCO, OSCE, and the U.S. Embassy in past years.

"I am grateful to the organizers of the competition, to the USAID TB Control Program, and to my fellow journalists who contributed their articles to the website. This is our joint victory. I am planning to continue to grow the website and publish articles so that I can continue to contribute to combatting this disease" - noted Iqboldjon Abdujabborov.

USAID supports the Republic of Uzbekistan Ministry of Health in implementing the National TB Program by providing more effective and accessible TB prevention, diagnosis, and treatment for all, including vulnerable populations. The main objective of the five-year, $7.6 million USAID TB Control Program is to reduce the burden of tuberculosis and prevent multidrug-resistant forms of the disease. The program covers a wide range of technical areas, including strengthening the health system’s human and institutional capacity, improving interagency coordination and cooperation, and increasing access to TB diagnosis and treatment.